Oral immunotherapy in children with cow's milk allergy by enzyme digested milk peptides
Not Applicable
- Conditions
- cow's milk allergy
- Registration Number
- JPRN-UMIN000002139
- Lead Sponsor
- Graduate School of Medicine, Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with cow's milk allergy who have intolerable reaction to enzyme digested milk peptides or diluted cow's milk.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The tolerance induction of the patients with cow's milk allergy by taking the enzyme digested milk peptides or cow's milk.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie enzyme digested milk peptide immunotherapy for cow's milk allergy in children?
How does oral immunotherapy with enzyme digested milk peptides compare to standard-of-care treatments for cow's milk allergy in pediatric populations?
Which biomarkers are associated with successful desensitization in children undergoing oral immunotherapy with enzyme digested milk peptides?
What are the potential adverse events and management strategies for enzyme digested milk peptide-based oral immunotherapy in pediatric cow's milk allergy patients?
Are there combination approaches or competitor drugs that enhance the efficacy of enzyme digested milk peptides in treating cow's milk allergy in children?